semaglutide study weight loss for Loss: How It Works, Comparisons, and More Weight loss in the STEP

According to FDA prescribing information, these effects vary by product and dose: For Ozempic (diabetes treatment): Nausea (15-20% of patients) Diarrhea (8-9% of patients) Vomiting (5-9% of patients) Constipation (3-7% of patients) Abdominal pain (5-6% of patients) For Wegovy (weight management), gastrointestinal effects are more common at the higher therapeutic dose: Nausea (up to 44% of patients) Diarrhea (up to 30% of patients) Vomiting (up to 24% of patients) Constipation (up to 24% of patients) Abdominal pain (up to 20% of patients) These effects are generally mild to moderate and tend to diminish with continued use

Diverticulitis is thought to occur when a piece of food becomes trapped in one of the bulges and bacteria start to multiply, triggering infection and inflammation

Patients should monitor their mood and behaviour

Mechanisms of peptide and nonpeptide ligand binding to class B G-protein coupled receptors

This matters because a clinic that prescribes hormones off a single test or a symptom questionnaire alone is skipping the step that protects you